- Home
- NOTV vs UCL Comparison
NOTV vs UCL Comparison
Compare NOTV & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- UCL
- Stock Information
- Founded
- NOTV 1974
- UCL 2014
- Country
- NOTV United States
- UCL Hong Kong
- Employees
- NOTV N/A
- UCL N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- NOTV Health Care
- UCL Consumer Discretionary
- Exchange
- NOTV Nasdaq
- UCL Nasdaq
- Market Cap
- NOTV 40.4M
- UCL 41.4M
- IPO Year
- NOTV 1997
- UCL 2020
- Fundamental
- Price
- NOTV $2.73
- UCL $1.18
- Analyst Decision
- NOTV Strong Buy
- UCL
- Analyst Count
- NOTV 3
- UCL 0
- Target Price
- NOTV $5.92
- UCL N/A
- AVG Volume (30 Days)
- NOTV 304.2K
- UCL 11.3K
- Earning Date
- NOTV 12-09-2024
- UCL 11-18-2024
- Dividend Yield
- NOTV N/A
- UCL N/A
- EPS Growth
- NOTV N/A
- UCL N/A
- EPS
- NOTV N/A
- UCL 0.12
- Revenue
- NOTV $501,062,000.00
- UCL $86,076,000.00
- Revenue This Year
- NOTV N/A
- UCL $11.23
- Revenue Next Year
- NOTV $8.69
- UCL $27.52
- P/E Ratio
- NOTV N/A
- UCL $10.09
- Revenue Growth
- NOTV N/A
- UCL 10.63
- 52 Week Low
- NOTV $1.23
- UCL $0.97
- 52 Week High
- NOTV $11.42
- UCL $2.56
- Technical
- Relative Strength Index (RSI)
- NOTV 64.06
- UCL 52.47
- Support Level
- NOTV $1.71
- UCL $0.99
- Resistance Level
- NOTV $3.60
- UCL $1.21
- Average True Range (ATR)
- NOTV 0.33
- UCL 0.08
- MACD
- NOTV 0.10
- UCL 0.01
- Stochastic Oscillator
- NOTV 54.69
- UCL 79.25
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.